Early Discovery of Ischemia After Replantation Surgery of the Extremities

Launched by OSLO UNIVERSITY HOSPITAL · Mar 17, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on improving the care of patients who have undergone replantation surgery for traumatic amputations, which means reattaching a severed limb. Researchers are testing a device called IscAlert, which continuously monitors the levels of carbon dioxide (CO2) in the tissue of the reattached limb. By tracking CO2 levels and temperature, the device can quickly alert doctors if there is a problem with blood flow in the area, which can lead to tissue damage. If issues are detected, doctors can assess the limb and, if necessary, perform another surgery to restore blood flow.

To participate in this study, patients must be at least 18 years old and need surgery to reattach a limb. There are no specific medical conditions that would exclude someone from joining. Participants can expect to have the IscAlert device placed in their limb for up to ten days after surgery, during which time their CO2 levels and temperature will be closely monitored. The goal is to ensure the best possible recovery and prevent complications after surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients must be in need of extremity replantation surgery
• • Subject must be ≥ 18 years
• • Able to give written signed informed consent
• Exclusion Criteria:
• • None